12 September 2023 Scandion Oncology appoints Lars Damstrup, MD, PhD, as new Chief Medical Officer Download Presentation Webcast Workbook
17 August 2023 Data from PANTAX trial to be presented at ESMO Congress 2023 Download Presentation Webcast Workbook
16 August 2023 Invitation to Scandion Oncology webcast and conference call August 23, 2023 Download Presentation Webcast Workbook
18 July 2023 The European Patent Office announces intention to grant of Composition-of-Matter patent for Scandion Oncology’s lead compound SCO-101 Download Presentation Webcast Workbook
26 April 2023 Scandion Oncology Announces Results of Annual General Meeting and Constitution of the Board of Directors Download Presentation Webcast Workbook
11 April 2023 Scandion Oncology – Notice convening the Annual General Meeting Download Presentation Webcast Workbook
31 March 2023 Scandion Oncology successfully completes the dose finding with lead compound SCO-101 in advanced pancreatic cancer patients (PANTAX phase Ib trial) Download Presentation Webcast Workbook
22 February 2023 Scandion Oncology – Q4 & year-end report 2022 Download Presentation Webcast Workbook
19 January 2023 Scandion Oncology A/S: Scandion Oncology receives favorable opinion from the European Patent Office on Composition of Matter Patent-application for lead compound SCO-101 Download Presentation Webcast Workbook